October 20, 2020

JSR Life Sciences Expands its European Gene-to-GMP Biologics Manufacturing Facilities for Selexis and KBI Biopharma in Geneva, Switzerland

Read More
October 16, 2020

Selexis Names Biopharmaceutical Executive Dirk Lange as New Chief Executive Officer

Read More
September 02, 2020

Igyxos and Selexis Enter Service Agreement to Advance Igyxos’ First-In-Class Monoclonal Antibody for the Treatment of Human Infertility

Read More

Media Downloads